Bullboard - Stock Discussion Forum Fulcrum Therapeutics Inc FULC

Healthcare

Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on improving the lives of patients with genetically defined rare diseases in areas of high unmet medical need. The Company’s clinical product candidate, losmapimod, is developed for the potential treatment of facioscapulohumeral muscular dystrophy (FSHD). Its other clinical product candidate is FTX... see more

Add To Watchlist

NDAQ:FULC - Post Discussion

Fulcrum Therapeutics Inc > Fulcrum Therapeutics, Inc. (FULC) Investigation: Bronstein,

View:

Post by whytestocks on Sep 18, 2024 9:30pm

Fulcrum Therapeutics, Inc. (FULC) Investigation: Bronstein,

News; $FULC Fulcrum Therapeutics, Inc. (FULC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the InvestigationNEW YORK, NY / ACCESSWIRE / September 18, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fulcrum Therapeutics, Inc. ("Fulcrum" or "the Company") (NASDAQ:FULC). Investors who purchased Fulcrum securities are encouraged to obtain addition...FULC - Fulcrum Therapeutics, Inc. (FULC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation